Enhanced γ-glutamylcysteine synthetase activity decreases drug-induced oxidative stress levels and cytotoxicity

Gokul C. Das, Attila Bacsi, Meena Shrivastav, Tapas Hazra, Istvan Boldogh

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Multidrug resistance of cancer cells can be intrinsic or acquired and occurs due to various reasons, including increased repair of genotoxic damage, an enhanced ability to remove/detoxify chemical agents, or reactive oxygen species (ROS), and repression of apoptosis. Human A2780/100 ovarian carcinoma cells exhibit resistance to DNA cross-linking agents, chlorambucil (Cbl), cisplatin (Cpl), melphalan (Mel), and ionizing radiation (IR) compared to the parental cell line, A2780. In the present study, we show that when A2780/100 and A2780 cells were treated with Cbl, GSH was extruded via methionine or cystathionine-inhibitable transporters of intact plasma membrane. GSH loss was followed by a rapid increase in ROS levels. The resistant, but not drug-sensitive cells normalized the intracellular GSH concentration along with ROS levels within 4-6 h after Cbl addition, and survived drug treatment. Normalization of GSH and ROS levels in A2780/100 cells correlated well with elevated γ-glutamylcysteine synthetase (γ-GCS) activity (10 ± 1.8-fold over A2780 cells). Ectopic overexpression of the γ-GCS heavy subunit in drug-sensitive cells nearly restored GSH and ROS to pre-treatment levels consequently increased cellular resistance to genotoxic agents (Cbl, Cpl, and IR), while overexpression of γ-GCS light subunit had no such effects. Thus, in our model system, drug-resistant cells have the inherent ability to maintain increased γ-GCS activity, reestablish physiological GSH, and cellular redox state and maintain increased cellular resistance to DNA cross-linking agents and IR.

Original languageEnglish (US)
Pages (from-to)635-647
Number of pages13
JournalMolecular Carcinogenesis
Volume45
Issue number9
DOIs
StatePublished - Sep 2006

Fingerprint

Glutamate-Cysteine Ligase
Oxidative Stress
Chlorambucil
Reactive Oxygen Species
Pharmaceutical Preparations
Ionizing Radiation
Cisplatin
Cystathionine
Melphalan
DNA
Multiple Drug Resistance
Methionine
Oxidation-Reduction
Cell Membrane
Apoptosis
Carcinoma
Light
Cell Line

Keywords

  • γ-glutamylcysteine synthetase
  • Drug resistance
  • ROS

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology

Cite this

Enhanced γ-glutamylcysteine synthetase activity decreases drug-induced oxidative stress levels and cytotoxicity. / Das, Gokul C.; Bacsi, Attila; Shrivastav, Meena; Hazra, Tapas; Boldogh, Istvan.

In: Molecular Carcinogenesis, Vol. 45, No. 9, 09.2006, p. 635-647.

Research output: Contribution to journalArticle

@article{cde872a7170849c19d42e5bce84fafe9,
title = "Enhanced γ-glutamylcysteine synthetase activity decreases drug-induced oxidative stress levels and cytotoxicity",
abstract = "Multidrug resistance of cancer cells can be intrinsic or acquired and occurs due to various reasons, including increased repair of genotoxic damage, an enhanced ability to remove/detoxify chemical agents, or reactive oxygen species (ROS), and repression of apoptosis. Human A2780/100 ovarian carcinoma cells exhibit resistance to DNA cross-linking agents, chlorambucil (Cbl), cisplatin (Cpl), melphalan (Mel), and ionizing radiation (IR) compared to the parental cell line, A2780. In the present study, we show that when A2780/100 and A2780 cells were treated with Cbl, GSH was extruded via methionine or cystathionine-inhibitable transporters of intact plasma membrane. GSH loss was followed by a rapid increase in ROS levels. The resistant, but not drug-sensitive cells normalized the intracellular GSH concentration along with ROS levels within 4-6 h after Cbl addition, and survived drug treatment. Normalization of GSH and ROS levels in A2780/100 cells correlated well with elevated γ-glutamylcysteine synthetase (γ-GCS) activity (10 ± 1.8-fold over A2780 cells). Ectopic overexpression of the γ-GCS heavy subunit in drug-sensitive cells nearly restored GSH and ROS to pre-treatment levels consequently increased cellular resistance to genotoxic agents (Cbl, Cpl, and IR), while overexpression of γ-GCS light subunit had no such effects. Thus, in our model system, drug-resistant cells have the inherent ability to maintain increased γ-GCS activity, reestablish physiological GSH, and cellular redox state and maintain increased cellular resistance to DNA cross-linking agents and IR.",
keywords = "γ-glutamylcysteine synthetase, Drug resistance, ROS",
author = "Das, {Gokul C.} and Attila Bacsi and Meena Shrivastav and Tapas Hazra and Istvan Boldogh",
year = "2006",
month = "9",
doi = "10.1002/mc.20184",
language = "English (US)",
volume = "45",
pages = "635--647",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "9",

}

TY - JOUR

T1 - Enhanced γ-glutamylcysteine synthetase activity decreases drug-induced oxidative stress levels and cytotoxicity

AU - Das, Gokul C.

AU - Bacsi, Attila

AU - Shrivastav, Meena

AU - Hazra, Tapas

AU - Boldogh, Istvan

PY - 2006/9

Y1 - 2006/9

N2 - Multidrug resistance of cancer cells can be intrinsic or acquired and occurs due to various reasons, including increased repair of genotoxic damage, an enhanced ability to remove/detoxify chemical agents, or reactive oxygen species (ROS), and repression of apoptosis. Human A2780/100 ovarian carcinoma cells exhibit resistance to DNA cross-linking agents, chlorambucil (Cbl), cisplatin (Cpl), melphalan (Mel), and ionizing radiation (IR) compared to the parental cell line, A2780. In the present study, we show that when A2780/100 and A2780 cells were treated with Cbl, GSH was extruded via methionine or cystathionine-inhibitable transporters of intact plasma membrane. GSH loss was followed by a rapid increase in ROS levels. The resistant, but not drug-sensitive cells normalized the intracellular GSH concentration along with ROS levels within 4-6 h after Cbl addition, and survived drug treatment. Normalization of GSH and ROS levels in A2780/100 cells correlated well with elevated γ-glutamylcysteine synthetase (γ-GCS) activity (10 ± 1.8-fold over A2780 cells). Ectopic overexpression of the γ-GCS heavy subunit in drug-sensitive cells nearly restored GSH and ROS to pre-treatment levels consequently increased cellular resistance to genotoxic agents (Cbl, Cpl, and IR), while overexpression of γ-GCS light subunit had no such effects. Thus, in our model system, drug-resistant cells have the inherent ability to maintain increased γ-GCS activity, reestablish physiological GSH, and cellular redox state and maintain increased cellular resistance to DNA cross-linking agents and IR.

AB - Multidrug resistance of cancer cells can be intrinsic or acquired and occurs due to various reasons, including increased repair of genotoxic damage, an enhanced ability to remove/detoxify chemical agents, or reactive oxygen species (ROS), and repression of apoptosis. Human A2780/100 ovarian carcinoma cells exhibit resistance to DNA cross-linking agents, chlorambucil (Cbl), cisplatin (Cpl), melphalan (Mel), and ionizing radiation (IR) compared to the parental cell line, A2780. In the present study, we show that when A2780/100 and A2780 cells were treated with Cbl, GSH was extruded via methionine or cystathionine-inhibitable transporters of intact plasma membrane. GSH loss was followed by a rapid increase in ROS levels. The resistant, but not drug-sensitive cells normalized the intracellular GSH concentration along with ROS levels within 4-6 h after Cbl addition, and survived drug treatment. Normalization of GSH and ROS levels in A2780/100 cells correlated well with elevated γ-glutamylcysteine synthetase (γ-GCS) activity (10 ± 1.8-fold over A2780 cells). Ectopic overexpression of the γ-GCS heavy subunit in drug-sensitive cells nearly restored GSH and ROS to pre-treatment levels consequently increased cellular resistance to genotoxic agents (Cbl, Cpl, and IR), while overexpression of γ-GCS light subunit had no such effects. Thus, in our model system, drug-resistant cells have the inherent ability to maintain increased γ-GCS activity, reestablish physiological GSH, and cellular redox state and maintain increased cellular resistance to DNA cross-linking agents and IR.

KW - γ-glutamylcysteine synthetase

KW - Drug resistance

KW - ROS

UR - http://www.scopus.com/inward/record.url?scp=33748809210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748809210&partnerID=8YFLogxK

U2 - 10.1002/mc.20184

DO - 10.1002/mc.20184

M3 - Article

VL - 45

SP - 635

EP - 647

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 9

ER -